Global CAR-T Cell Therapy Solution Market 2023 by Company, Regions, Type and Application, Forecast to 2029

1 Market Overview

• 1.1 Product Overview and Scope of CAR-T Cell Therapy Solution
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of CAR-T Cell Therapy Solution by Type
  • 1.3.1 Overview: Global CAR-T Cell Therapy Solution Market Size by Type: 2018 Versus 2022 Versus 2029
  • 1.3.2 Global CAR-T Cell Therapy Solution Consumption Value Market Share by Type in 2022
  • 1.3.3 CD19 CAR Cell Therapy
  • 1.3.4 BCMA CAR Cell Therapy
• 1.4 Global CAR-T Cell Therapy Solution Market by Application
  • 1.4.1 Overview: Global CAR-T Cell Therapy Solution Market Size by Application: 2018 Versus 2022 Versus 2029
  • 1.4.2 Leukemia
  • 1.4.3 Lymphoma
  • 1.4.4 Myeloma
  • 1.4.5 Others
• 1.5 Global CAR-T Cell Therapy Solution Market Size & Forecast
• 1.6 Global CAR-T Cell Therapy Solution Market Size and Forecast by Region
  • 1.6.1 Global CAR-T Cell Therapy Solution Market Size by Region: 2018 VS 2022 VS 2029
  • 1.6.2 Global CAR-T Cell Therapy Solution Market Size by Region, (2018-2029)
  • 1.6.3 North America CAR-T Cell Therapy Solution Market Size and Prospect (2018-2029)
  • 1.6.4 Europe CAR-T Cell Therapy Solution Market Size and Prospect (2018-2029)
  • 1.6.5 Asia-Pacific CAR-T Cell Therapy Solution Market Size and Prospect (2018-2029)
  • 1.6.6 South America CAR-T Cell Therapy Solution Market Size and Prospect (2018-2029)
  • 1.6.7 Middle East and Africa CAR-T Cell Therapy Solution Market Size and Prospect (2018-2029)

2 Company Profiles

• 2.1 Thermo Fisher Scientific
  • 2.1.1 Thermo Fisher Scientific Details
  • 2.1.2 Thermo Fisher Scientific Major Business
  • 2.1.3 Thermo Fisher Scientific CAR-T Cell Therapy Solution Product and Solutions
  • 2.1.4 Thermo Fisher Scientific CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
• 2.2 Q2 Solutions
  • 2.2.1 Q2 Solutions Details
  • 2.2.2 Q2 Solutions Major Business
  • 2.2.3 Q2 Solutions CAR-T Cell Therapy Solution Product and Solutions
  • 2.2.4 Q2 Solutions CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.2.5 Q2 Solutions Recent Developments and Future Plans
• 2.3 Agilent Technologies
  • 2.3.1 Agilent Technologies Details
  • 2.3.2 Agilent Technologies Major Business
  • 2.3.3 Agilent Technologies CAR-T Cell Therapy Solution Product and Solutions
  • 2.3.4 Agilent Technologies CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.3.5 Agilent Technologies Recent Developments and Future Plans
• 2.4 Genscript Biotech
  • 2.4.1 Genscript Biotech Details
  • 2.4.2 Genscript Biotech Major Business
  • 2.4.3 Genscript Biotech CAR-T Cell Therapy Solution Product and Solutions
  • 2.4.4 Genscript Biotech CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.4.5 Genscript Biotech Recent Developments and Future Plans
• 2.5 Sino Biological
  • 2.5.1 Sino Biological Details
  • 2.5.2 Sino Biological Major Business
  • 2.5.3 Sino Biological CAR-T Cell Therapy Solution Product and Solutions
  • 2.5.4 Sino Biological CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.5.5 Sino Biological Recent Developments and Future Plans
• 2.6 Nuowei Biotechnology
  • 2.6.1 Nuowei Biotechnology Details
  • 2.6.2 Nuowei Biotechnology Major Business
  • 2.6.3 Nuowei Biotechnology CAR-T Cell Therapy Solution Product and Solutions
  • 2.6.4 Nuowei Biotechnology CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.6.5 Nuowei Biotechnology Recent Developments and Future Plans
• 2.7 Novartis
  • 2.7.1 Novartis Details
  • 2.7.2 Novartis Major Business
  • 2.7.3 Novartis CAR-T Cell Therapy Solution Product and Solutions
  • 2.7.4 Novartis CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.7.5 Novartis Recent Developments and Future Plans
• 2.8 JW Therapeutics
  • 2.8.1 JW Therapeutics Details
  • 2.8.2 JW Therapeutics Major Business
  • 2.8.3 JW Therapeutics CAR-T Cell Therapy Solution Product and Solutions
  • 2.8.4 JW Therapeutics CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.8.5 JW Therapeutics Recent Developments and Future Plans
• 2.9 Sorrento Therapeutics
  • 2.9.1 Sorrento Therapeutics Details
  • 2.9.2 Sorrento Therapeutics Major Business
  • 2.9.3 Sorrento Therapeutics CAR-T Cell Therapy Solution Product and Solutions
  • 2.9.4 Sorrento Therapeutics CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.9.5 Sorrento Therapeutics Recent Developments and Future Plans
• 2.10 Gilead Sciences
  • 2.10.1 Gilead Sciences Details
  • 2.10.2 Gilead Sciences Major Business
  • 2.10.3 Gilead Sciences CAR-T Cell Therapy Solution Product and Solutions
  • 2.10.4 Gilead Sciences CAR-T Cell Therapy Solution Revenue, Gross Margin and Market Share (2018-2023)
  • 2.10.5 Gilead Sciences Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global CAR-T Cell Therapy Solution Revenue and Share by Players (2018-2023)
• 3.2 Market Share Analysis (2022)
  • 3.2.1 Market Share of CAR-T Cell Therapy Solution by Company Revenue
  • 3.2.2 Top 3 CAR-T Cell Therapy Solution Players Market Share in 2022
  • 3.2.3 Top 6 CAR-T Cell Therapy Solution Players Market Share in 2022
• 3.3 CAR-T Cell Therapy Solution Market: Overall Company Footprint Analysis
  • 3.3.1 CAR-T Cell Therapy Solution Market: Region Footprint
  • 3.3.2 CAR-T Cell Therapy Solution Market: Company Product Type Footprint
  • 3.3.3 CAR-T Cell Therapy Solution Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global CAR-T Cell Therapy Solution Consumption Value and Market Share by Type (2018-2023)
• 4.2 Global CAR-T Cell Therapy Solution Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

• 5.1 Global CAR-T Cell Therapy Solution Consumption Value Market Share by Application (2018-2023)
• 5.2 Global CAR-T Cell Therapy Solution Market Forecast by Application (2024-2029)

6 North America

• 6.1 North America CAR-T Cell Therapy Solution Consumption Value by Type (2018-2029)
• 6.2 North America CAR-T Cell Therapy Solution Consumption Value by Application (2018-2029)
• 6.3 North America CAR-T Cell Therapy Solution Market Size by Country
  • 6.3.1 North America CAR-T Cell Therapy Solution Consumption Value by Country (2018-2029)
  • 6.3.2 United States CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)
  • 6.3.3 Canada CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)
  • 6.3.4 Mexico CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)

7 Europe

• 7.1 Europe CAR-T Cell Therapy Solution Consumption Value by Type (2018-2029)
• 7.2 Europe CAR-T Cell Therapy Solution Consumption Value by Application (2018-2029)
• 7.3 Europe CAR-T Cell Therapy Solution Market Size by Country
  • 7.3.1 Europe CAR-T Cell Therapy Solution Consumption Value by Country (2018-2029)
  • 7.3.2 Germany CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)
  • 7.3.3 France CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)
  • 7.3.4 United Kingdom CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)
  • 7.3.5 Russia CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)
  • 7.3.6 Italy CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)

8 Asia-Pacific

• 8.1 Asia-Pacific CAR-T Cell Therapy Solution Consumption Value by Type (2018-2029)
• 8.2 Asia-Pacific CAR-T Cell Therapy Solution Consumption Value by Application (2018-2029)
• 8.3 Asia-Pacific CAR-T Cell Therapy Solution Market Size by Region
  • 8.3.1 Asia-Pacific CAR-T Cell Therapy Solution Consumption Value by Region (2018-2029)
  • 8.3.2 China CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)
  • 8.3.3 Japan CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)
  • 8.3.4 South Korea CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)
  • 8.3.5 India CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)
  • 8.3.6 Southeast Asia CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)
  • 8.3.7 Australia CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)

9 South America

• 9.1 South America CAR-T Cell Therapy Solution Consumption Value by Type (2018-2029)
• 9.2 South America CAR-T Cell Therapy Solution Consumption Value by Application (2018-2029)
• 9.3 South America CAR-T Cell Therapy Solution Market Size by Country
  • 9.3.1 South America CAR-T Cell Therapy Solution Consumption Value by Country (2018-2029)
  • 9.3.2 Brazil CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)
  • 9.3.3 Argentina CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)

10 Middle East & Africa

• 10.1 Middle East & Africa CAR-T Cell Therapy Solution Consumption Value by Type (2018-2029)
• 10.2 Middle East & Africa CAR-T Cell Therapy Solution Consumption Value by Application (2018-2029)
• 10.3 Middle East & Africa CAR-T Cell Therapy Solution Market Size by Country
  • 10.3.1 Middle East & Africa CAR-T Cell Therapy Solution Consumption Value by Country (2018-2029)
  • 10.3.2 Turkey CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)
  • 10.3.3 Saudi Arabia CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)
  • 10.3.4 UAE CAR-T Cell Therapy Solution Market Size and Forecast (2018-2029)

11 Market Dynamics

• 11.1 CAR-T Cell Therapy Solution Market Drivers
• 11.2 CAR-T Cell Therapy Solution Market Restraints
• 11.3 CAR-T Cell Therapy Solution Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry
• 11.5 Influence of COVID-19 and Russia-Ukraine War
  • 11.5.1 Influence of COVID-19
  • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

• 12.1 CAR-T Cell Therapy Solution Industry Chain
• 12.2 CAR-T Cell Therapy Solution Upstream Analysis
• 12.3 CAR-T Cell Therapy Solution Midstream Analysis
• 12.4 CAR-T Cell Therapy Solution Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source